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The conceptual framework and assessment
methodology for the systematic reviews of
community-based interventions for the prevention
and control of infectious diseases of poverty
Zohra S Lassi1, Rehana A Salam1, Jai K Das1 and Zulfiqar A Bhutta2,3*
Abstract
This paper describes the conceptual framework and the methodology used to guide the systematic reviews of
community-based interventions (CBIs) for the prevention and control of infectious diseases of poverty (IDoP). We
adapted the conceptual framework from the 3ie work on the ‘Community-Based Intervention Packages for Preventing
Maternal Morbidity and Mortality and Improving Neonatal Outcomes’ to aid in the analyzing of the existing CBIs for IDoP.
The conceptual framework revolves around objectives, inputs, processes, outputs, outcomes, and impacts showing the
theoretical linkages between the delivery of the interventions targeting these diseases through various community deliv-
ery platforms and the consequent health impacts. We also describe the methodology undertaken to conduct the sys-
tematic reviews and the meta-analyses.
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Multilingual abstracts
Please see Additional file 1 for translations of the
abstract into the six official working languages of the
United Nations.
Introduction
Infectious diseases of poverty (IDoPs), including neglected
tropical diseases (NTDs), malaria, tuberculosis (TB)
and HIV/AIDS, disproportionately affect the poorest
populations in the world. A large proportion of infectious
diseases in low- and middle- income countries (LMICs) are
entirely avoidable or treatable with existing interventions
and drugs [1]. The previous publication has discussed in
detail the prevailing burden, distribution, and existing
interventions for the prevention and control of IDoPs,
while this paper describes the conceptual framework and
methods used to guide the systematic reviews. We adapted
the conceptual framework from the 3ie work [2] to analyze
how existing community-based interventions (CBIs) can
prevent and control IDoPs (see Figure 1). The 3ie
framework was used to evaluate the effectiveness of CBI
packages for maternal, perinatal, and neonatal health out-
comes. It shows the theoretical linkages between the CBI
packages, utilizing community health workers (CHWs), as
well as the health outcomes and access to care [2]. We
have modified this framework to incorporate the CBIs
pertaining to IDoPs, and their impacts.
Review
Conceptual framework
The conceptual framework revolves around objectives,
inputs, processes, outputs, outcomes, and impacts. It
shows linkages between the delivery of the interventions
targeting IDoPs through various community delivery
platforms and their consequent impacts. The framework
is based on capacity building and training for the delivery of
preventive and curative interventions in community settings,
either integrated with the existing health services or vertically
administered. Some of these CBIs are comprehensive and
target a range of diseases. Such CBIs include community
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mobilization, education and training, financial incentives,
and referrals to health facilities. Other CBIs, however, are
disease focused and include, for instance, the provision of
disease specific preventive and curative chemotherapy.
Community mobilization comprises the formation of
support groups, educating community members on
recognizing the danger signs early, and the use of mass
media campaigns. The removal of financial barriers
involves conditional cash transfers (CCTs), vouchers, and
pay for performance. Community-based health promotion
and preventive interventions include environmental
modification; water, sanitation, and hygiene (WASH)
interventions; vector control; and mass drug administration
(MDA). Curative interventions include disease-specific
diagnosis, treatment, and rehabilitation. Referral encom-
passes early diagnosis, treatment initiation, and institutional
care for complicated and non-complicated cases. These
interventions, when implemented in a synergistic manner,
will lead to positive changes at the household, community,
and facility levels. These changes would in turn improve
knowledge, attitude and practices (KAP), coverage and ac-
cess, and lead to reduced morbidity and mortality related
to IDoPs. In this paper, we describe the components of our
conceptual framework on all levels: inputs, processes,
outputs, outcomes, and impacts. This paper also details
the methodology used for conducting the systematic
reviews and meta-analyses.
Inputs and processes
Capacity building and training
According to the World Health Organization (WHO),
there is a shortage of 7.2 million healthcare workers
globally, with developing countries facing the heft of this
burden [3]. Fifty-seven countries have critical shortages of
healthcare workers and 36 of these are in Sub-Saharan
Africa, which has 25% of the world’s burden of disease
with only 3% of the world’s healthcare workers to cater to
it. Health service delivery through an alternate cadre of
skilled and semi-skilled workers has been practiced all
over the world for the past several decades, however more
Figure 1 The conceptual framework for integrated community-based interventions for NTDs.
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recently, due to the growing human resource crisis espe-
cially in LMICs, the role of task shifting has re-emerged in
order to provide services to ‘hard-to-reach’ groups [4-7].
Thus, increasing the number of CHWs, training and
educating them, providing them with incentives, and
improving the infrastructure to reduce turnover is
crucial for the community-based prevention and con-
trol of these infectious diseases. Community health
worker programs have increasingly been receiving
greater attention over the last few years and a num-
ber of publications have documented the impact of
such programs [8-11]. The Access Project which sets
out to control NTDs in Rwanda and the lymphatic filar-
iasis (LF) control program in Togo are among a few of
the recent examples where CHWs were successfully
employed and trained to undertake screening and
MDA campaigns to achieve effective control [12,13].
Training school teachers and personnel is another
cost-effective way to administer MDA and successful
examples exist where teachers have administered
albendazole (ABZ) and praziquantel (PZQ) for soil-
transmitted helminthiasis (STH) and schistosomiasis.
The Bangladesh Rural Advancement Committee
(BRAC) is also one of the laudable initiatives, under which
70,000 CHWs continue to work and are connected to a
functioning health system [14]. These CHWs earn an in-
come by identifying TB patients and ensuring treatment
completion by providing directly observed treatment. An
alternative cadre of CHWs involved in drug and
equipment supply are the community-based vendors
and medicine sellers. Medicine sellers have played an im-
portant role in facilitating access to essential medicines and
the distribution of insecticide-treated nets (ITNs) in Sub-
Saharan Africa. The training and capacity building of these
individuals has aided in bringing about appropriate de-
mand, and in enhancing quality assurance and com-
munity acceptability [14].
Community mobilization and education
It is well recognized that community participation is im-
portant for the successful delivery of health services at the
community level [15]. Community-based support groups
and women’s groups comprising community representa-
tives are increasingly becoming a core component of com-
munity service packages. It is a key part of successful drug
compliance for preventive as well as therapeutic regimens
as it emphasizes the importance of treatment completion,
helps to communicate key concepts, ensures sustainability
and accountability, and addresses the myths related to
IDoPs. Health education plays a pivotal role in prevention
and control as many of these diseases can be successfully
prevented and controlled with vector control and WASH
strategies. Many NTD programs include community
mobilization and education as core components, for
example, the Tanzania NTD Control Program supported
by Envision and the End NTDs in Africa programs in
Ghana and Sierra Leone.
Removal of financial barriers
In resource-limited settings, IDoPs are compounded by
low investment in health, lack of comprehensive health
financing policies, limited financial access to health, and
extensive out-of-pocket payments. To ameliorate poverty
and improve healthcare access for the poor and marginal-
ized population, various financial mechanisms have been
devised, tested, and implemented at scale. These strategies
improve the uptake of desired health services that are
otherwise constrained by the lack of financial prowess, and
also provide household economic stability and help alleviate
poverty. They involve the provision of monetary benefits as
a source of motivation for desired health-related actions
and free access to basic healthcare, thus creating a demand
for health services. Diverse and innovative financial support
platforms are being implemented in some of the fragile
states such as Cambodia, Afghanistan, Pakistan and Haiti,
as well as in the more established economies of Latin
American countries, to improve overall maternal and child
health [16,17]. In the domain of IDoPs, potential promising
impacts have been seen for improving the uptake of ITNs
through vouchers and social marketing, while cash transfers
and food and nutrition support have shown some impact
on reducing vulnerability to HIV/AIDS among adolescent
girls and young women [18-20]. However, financial incen-
tives are yet to be formally evaluated for effectiveness
against IDoP and any measurable effects from rigorous
evaluations have not been reported as yet [18-20].
Health promotion and preventive interventions
To break the cycle of infections, health promotion and
preventive interventions are critical. Since many of these
diseases are vector borne or transmitted through poor
sanitation and hygiene conditions, they can be averted if
effective preventive measures are in place. For effective
control of dengue, chagas, human African trypanosomiasis,
leishmaniasis, dracunculiasis, LF, onchocerciasis and
schistosomiasis, vector control mainly relies on insecticides.
An effective sanitation infrastructure is ideal for interrupting
the transmission of many diseases, however, the resources
are limited and not sustainable in developing countries
[21]. Preventive chemotherapy is the most feasible
and cost-effective measure as safe and effective drugs
exist [22,23]. Programs to control NTDs predominantly
employ MDA to treat high-risk population [24] and WHO
endorses this strategy as ‘preventative chemotherapy’ [25].
For some of these diseases, chemotherapy is common and
can be administered concurrently, for example, ABZ is
given to treat LF and STH, while ivermectin (IVR) can be
given for both LF and onchocerciasis [26]. Other preventive
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strategies involve community-based vector control
measures such as insecticide spraying and ITNs for
dengue, chagas, and leishmaniasis.
Of the various measures in place for malaria prevention,
key interventions include indoor residual spraying (IRS),
use of ITNs, intermittent preventive therapy (IPT), pre-
sumptive treatment, and mass awareness. In Sub-Saharan
Africa, the wide-scale implementation of ITNs is now one
of the main strategies to reduce malaria morbidity and
mortality [27]. The ITNs have the potential to hugely affect
the spread of this disease, and their use has been associated
with reduced mortality among children [28-30]. The
WHO also recommends IPT for pregnant women and in-
fants in highly endemic areas.
For HIV prevention, interventions must involve
behavioral changes to reduce HIV risk and promote
awareness about condom use, safe sex practices, voluntary
testing and counseling, and voluntary male circumcision.
Couples counseling and condom distribution have proven
effective in many countries such as Kenya and Zambia,
however, many countries still lack a comprehensive strategy
for rolling out these programmatic approaches [19].
Therapeutic interventions
Therapeutic control of NTDs recommended by the
WHO involves periodic administration of ABZ and
mebendazole (MBZ) for STH, PZQ for schistosomiasis,
and IVR or diethylcarbamazine (DEC) for LF once or
twice a year depending on the baseline prevalence
among the populations at risk [31]. For trachoma, the
WHO recommends the SAFE (surgery, azithromycin,
facial cleanliness, and environmental hygiene) strategy,
while for leprosy, multidrug therapy is recommended.
For the treatment of malaria, the artemisinin-based
combination therapy is recommended. Tuberculosis is
completely curable through WHO’s Stop TB Strategy
(founded on the core of the DOTS strategy). It is based on
the prompt diagnosis of the active disease and followed by
supervised, short-course combination chemotherapy, as
recommended. Ensuring completion of treatment is
crucial for the prevention of relapse and secondary drug
resistance. Since 1995, 41 million people have been
successfully treated and up to six million lives have been
saved through DOTS and the Stop TB Strategy [32].
The treatment of HIV involves antiretroviral therapy
(ART) regimens to effectively reduce the risk of HIV
transmission. Pregnant women living with HIV should
also be treated with recommended regimens to prevent
mother-to-child transmission (MTCT) [19].
Referrals
An effective referral system ensures a close relationship
between all levels of the health system and helps to
ensure the best possible health care [33]. Support for
CHWs by experienced staff from the district health
facility helps build capacity and enhance access to
better quality care. Programs focusing on the prevention
and management of IDoPs should also strengthen referral
services alongside active case detection to manage and
rehabilitate diagnosed chronic cases with incapacitating
conditions. This will ensure optimal care at appropriate
time, avoid unnecessary costs, and provide timely
treatment.
Community delivery platforms
Community delivery platforms deliver a range of health
services to meet local community needs and are increasingly
being advocated to improve nutrition and control diseases
[8,9]. Various community delivery platforms can be utilized
for the prevention and control of IDoPs. The school system
offers an ideal setting for deworming and provision of
health education messages to children. Anthelmintics can
be delivered by school teachers as medicines are safe to
administer with minimal training, thus making the practice
cost effective. In 2010, a review of costs in seven countries
in four WHO regions estimated that the average cost of
treating one million children was US$ 72,000 (or 7.2 cents
per child). This estimate included procurement and
distribution of medicines, training of teachers, and super-
vision and monitoring [34]. Vaccination and supplemen-
tary campaigns (for example, vitamin A distribution) also
provide opportunities to deworm preschool-age children,
and it is shown that deworming usually increases the
coverage of vaccination and supplementary campaigns
[35]. Since the infrastructure and personnel are already
in place to distribute vitamins or vaccines, they can
easily administer deworming tablets at a minimum
added cost. Pregnant women and women of reproduct-
ive age can be easily targeted for IPT and ART through
existing community-based maternal and child health
services and this is feasible even in resource-poor set-
tings [36]. Large-scale administration of these drugs
should be incorporated, along with other associated
activities such as staff training, data collection, and
development of materials for advocacy and commu-
nity mobilization.
The interventions identified in our conceptual framework
are diverse, but the ultimate goal of these interventions is
to reduce the prevalence and morbidities associated with
IDoPs. We would like to emphasize that these components
work in parallel with each other to bring about a synergistic
effect. With this understanding of the effective model of
delivering CBIs for prevention and control of IDoPs, we
aim to achieve improvements at household (knowledge, be-
havior, and care seeking); community/facility (ownership,
quality of care, early detection, and management); and
environmental (sustainability and improved environment)
levels. These outputs would eventually lead to broader
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outcomes and impacts such as improved access and
coverage of interventions and consequent decreases in
prevalence, associated morbidities, and mortalities of
these diseases.
Methods
We conducted systematic reviews of all studies focusing on
existing community-based interventions for IDoPs. Guided
by our conceptual framework, we focused on studies evalu-
ating the effectiveness of CBIs targeting the 14 major NTDs
(leishmaniasis, human African trypanosomiasis, chagas dis-
ease, dengue, trachoma, leprosy, buruli ulcer, and the
helminthes including hookworm, ascariasis, trichuria-
sis, LF, onchocerciasis, dracunculiasis and schistosom-
iasis); malaria; TB; and HIV/AIDs compared to
routine healthcare delivery. For these reviews, we
have categorized NTDs into helminthic and non-
helminthic diseases, and report the findings accordingly
in separate papers. Helminthic diseases included STH such
as ascariasis, hookworm and trichuriasis, along with schis-
tosomiasis, LF, onchocerciasis, and dracunculiasis. Non-
helminthic diseases included dengue, African trypanosom-
iasis, chagas, leishmaniasis, trachoma, leprosy, and bur-
uli ulcer. In this review, we have used the following
definitions for CBIs, integrated CBIs, and additional
training:
 A ‘community-based intervention’ was defined as any
intervention or care package delivered by healthcare
personnel or lay individuals at home, village, or any
defined community setting, but not in a health facility.
Such intervention packages might include additional
training for outreach workers, namely lady health
workers/visitors, community midwives, community/
village health workers, or facilitators to deliver
interventions related to prevention and control of the
outlined infectious diseases. The CBIs also included
any financial interventions to improve uptake of the
desired health services which are otherwise constrained
by lack of financial resources.
 ‘Integrated CBIs’ were defined as interventions
merged into any existing program, for example,
routine maternal child health programs or primary
healthcare setups.
 ‘Additional training’ was defined as any training
other than the routine training that healthcare
workers or CHWs received from governmental or
non-governmental organizations (NGOs), and could
include didactic sessions, lectures, and supervised
hands-on training in a healthcare facility and/or
within the community.
We considered all available existing randomized,
quasi-randomized, and before-and-after studies measuring
the impact of CBIs to prevent and treat IDoPs. In addition,
other less rigorous study designs such as observational
(cohort and case–control) and descriptive studies were also
reviewed to understand the context within which they were
implemented, typology of healthcare providers, types of
intervention delivered, and reported results.
Search strategy and selection criteria
Studies were included if intervention was delivered within
community setting and if reported outcomes were rele-
vant to the diseases under review. We systematically
reviewed literature published before May 2013 to identify
relevant studies. Searches were conducted in PubMed,
Cochrane Libraries, Embase, and WHO Regional Data-
bases to identify all published and unpublished studies.
Additional studies were identified by hand searching refer-
ences from the included studies. A broad search strategy
was used that included a combination of appropriate
keywords, medical subject headings (MeSH), and free text
terms i.e. [(“Infectious diseases” OR “infectious diseases
in poor*” OR “infectious diseases of poverty” OR “malaria”
OR “tuberculosis” OR “TB” OR “HIV/AIDS” OR
“neglected tropical disease*” OR “NTD” OR “leishmania-
sis” OR “human African trypanosomiasis” OR “chagas
disease” OR “dengue” OR “trachoma” OR “leprosy” OR
“buruli ulcer” OR “helminth infection*” OR “STH” OR
“soil-transmitted helminth*” OR “ascariasis” OR “trichuria-
sis” OR “lymphatic filariasis” OR “onchocerciasis” OR “dra-
cunculiasis” OR “schistosomiasis”) AND (“community” OR
“community health aides” OR “primary health care” OR
“community health worker*” OR “lay health worker*”
OR “mid-level health worker*” OR “community-based
interventions” OR “outreach”)].
The abstracts and the full sources were screened by
two of the authors to identify if the studies adhered to
the set inclusion criteria. Any argument on selecting
studies between these two authors was resolved by the
third author. After full text retrieval of all eligible studies,
double data was abstracted from each study into a
standardized form to elicit the following information:
 Study design;
 Country, including settings (urban/rural);
 Intervention type (preventive/therapeutic);
 Intervention description;
 Mode of delivery (integrated or non-integrated); and
 Outcomes assessed.
Quality assessment
Two review authors independently assessed the risk of
bias for each study using the Cochrane risk of bias as-
sessment criteria [37]. This was based on sequence gen-
eration (checking for possible selection bias); allocation
concealment (checking for possible selection bias); blinding
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(checking for possible performance bias); incomplete
outcome data (checking for possible attrition bias
through withdrawals, dropouts, protocol deviations);
selective reporting bias; or any other sources of bias.
The above mentioned criteria were rated as ‘ad-
equately done’, ‘not done’, or ‘unclear’. The level of at-
trition was noted for each study and its impact on
the overall assessment of treatment effect was explored
by using sensitivity analysis, where possible. For all
outcomes, we carried out the analysis, as far as possible,
on an intention-to-treat basis.
Statistical analysis
We conducted a meta-analysis for individual studies and
pooled statistics were reported as the relative risk (RR)
for categorical variables and standard mean difference
(SMD) for continuous variables between the experimental
and control groups with 95% confidence intervals (CIs).
Mantel-Haenszel pooled RR and corresponding 95%
CIs were reported when there was no evidence of
heterogeneity. The DerSimonian and Laird pooled RR and
corresponding 95% CIs were reported where there was an
unexplained heterogeneity. All analyses were conducted
using the software Review Manager 5.1.
Assessment of heterogeneity
Heterogeneity was quantified by Chi2 and I2, which can
be interpreted as the percentage of the total variation
between studies that is attributable to heterogeneity rather
than to chance, a low p-value (less than 0.1), or a large
chi-squared statistic relative to its degree of freedom. I2
values greater than 50% were taken as a substantial and
high heterogeneity. In situations of high heterogeneity,
causes were explored by sensitivity analysis and random
effect models were used. The primary comparison was for
the community delivered interventions versus routine
health service delivery. However, where possible, we
also attempted to perform a subgroup analysis for the
integrated versus the non-integrated delivery. The subgroup
analysis was done for the following comparisons:
 A community-based delivery versus a routine
delivery of interventions;
 Integrated CBIs versus non-integrated CBIs;
 Evidence from randomized and quasi-randomized
studies versus pre-post study designs;
 A school-based delivery versus a routine delivery; and
 Preventive CBIs versus therapeutic CBIs.
 Types of intervention.
Sensitivity analysis was carried out to explain possible
heterogeneity in the summary estimates. We conducted
sensitivity analysis by removing high risk of bias study
from the pooled estimate and compared the estimate with
and without the study data. The level of attrition was
noted for each study and its impact on the overall
assessment of the effect of treatment was explored by
using sensitivity analysis.
Qualitative synthesis
We also attempted to qualitatively synthesize the findings
reported in the included studies for other pragmatic
parameters highlighted in our conceptual framework
that could not be quantitatively meta-analyzed. These
factors included intervention coverage, challenges/barriers,
enabling factors, aspects related to integrated delivery,
monitoring and evaluations, equity, etc. Given this causal
model, we aimed to systematically analyze available
evidence on the effectiveness of CBIs to prevent and treat
IDoPs, including helminthic NTDs, non-helminthic NTDs,
malaria, HIV/AIDs, and TB.
Conclusion
Based on the conceptual framework and the described
methodology, we have evaluated the impact of CBIs on
the outlined health outcomes. The findings from the
systematic reviews on helminthic NTDs non-helminthic
NTDs, malaria, HIV/AIDS, and TB are reported in
separate papers.
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